d-alpha tocopherol has been researched along with zithromax in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dasiuk, TIe | 1 |
1 review(s) available for d-alpha tocopherol and zithromax
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for d-alpha tocopherol and zithromax
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Complex personalized therapy of patients with chlamydiosis taking into consideration abnormalities of pro-oxidant-antioxidant and immune systems].
Topics: Adolescent; Adult; alpha-Tocopherol; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Chlamydia Infections; Chlamydia trachomatis; Coinfection; Female; Humans; Immunologic Factors; Male; Middle Aged; Oxidation-Reduction; Precision Medicine; Reactive Oxygen Species; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Trichomonas Infections; Trichomonas vaginalis; Urinary Tract Infections | 2013 |